Hepatitis C

The pCPA has completed negotiations with 3 manufacturers of drugs used to treat Hepatitis C The pan-Canadian Pharmaceutical Alliance (pCPA), in its first stand-alone statement, announced on February 21, 2017 that they have successfully negotiated agreements with Gilead, Merck, and Bristol Myers Squibb. There is one notable absence from this list – that of the 4th manufacturer of hepatitis C drugs, Abbvie who manufactures Holkira and Technivie. These … Read More →